Tag: EPA

Court Denies Most Challenges to TSCA Risk Evaluation Rule

An assemblage of environmental, public health, and worker rights groups filed three challenges in the U.S. Court of Appeals for the 9th Circuit against the chemical Risk Evaluation Rule the EPA issued in July 2017 as required by the 2016 amendments to the Toxic Substances Control Act (TSCA). Petitioners also challenged aspects of the Agency’s […]

Chemicals, chemical tanks

More Details on the EPA’s RMP Reconsideration Rule

Facilities subject to Section 112(r) of the Clean Air Act—better known as the Risk Management Program (RMP)—won a significant deregulatory victory with the EPA’s issuance of its RMP Reconsideration Rule. The Reconsideration Rule rescinds major portions of the RMP Amendments Rule the Obama EPA issued in January 2017.

EPA, Environmental Protection Agency

EPA Issues (De-)Regulatory Agenda, Priorities for 2020

The EPA’s commitment to regulatory reform through deregulation is evident in the Agency’s latest Regulatory Agenda. The 145 entries on the Agency’s Fall 2019 Rule List include 56 actions that are expected to be deregulatory; these actions follow the 47 deregulatory amendments the EPA says it has already finalized under President Donald Trump.

EPA, Environmental Protection Agency

EPA Finalizes Reconsideration of Risk Management Program Provisions

The U.S. Environmental Protection Agency (EPA) finalized its reconsideration of Risk Management Program provisions that were amended in 2017.  EPA opted to rescind some of the amended provisions for various reasons and retain or modify other provisions.  According to EPA, the latest revisions to the rule “better address potential security risks, reduce unnecessary and ineffective […]

EPA Headquarters

EPA Looks to Trim Authority of Environmental Appeals Board

With the goal of expediting resolution of objections to permits issued by the EPA under major environmental statutes, the Agency is proposing amendments to regulations governing its Environmental Appeals Board (EAB). Among the seven proposed revisions, the most significant would strengthen the role of the alternative dispute resolution (ADR) program. Other parts of the proposal […]

Pill bottles, pharmaceuticals

EPA’s Regulations on Waste Prescription and Nonprescription Pharmaceuticals

The EPA has long emphasized that the Resource Conservation and Recovery Act (RCRA) and its regulations were written to address the generation of solid and hazardous wastes by industrial plants and the storage, treatment, and disposal of such wastes at permitted facilities and landfills. What the regulations were not intended to cover is the generation […]

Chemical research, PFAS

PFAS: What We Know, What’s Being Studied, and the Laws

Many stakeholders are following—or should be following—the federal government’s plans to address the impact of per- and polyfluoroalkyl substances (PFAS) on human health and the environment. There is a lot to follow. PFAS are a family of chemicals first synthesized in the 1940s. It is a very large family. According to the EPA’s February 2019 […]

Chemist protecting confidential business information

Chemical CBI Claims: Reverse Engineering Questions Proposed by EPA

The EPA is proposing to add two questions to the list of questions chemical manufacturers (which include importers) and processors must answer to substantiate claims that the identities of chemicals must be protected from public disclosure. Both questions relate to reverse engineering, defined as a process “to disassemble and examine or analyze in detail (a […]